Article
The Myriad Decision In The U.S. Supreme Court
On March 26, 2012, the U.S. Supreme Court postponed answering the question of whether isolated DNA is patentable. Instead, the Supreme Court vacated the Federal Circuit's decision in AMP v. Myriad Genetics, and remanded the case for consideration in light of the Supreme Court’s March 20, 2012 decision in Mayo v. Prometheus.
Hunton Andrews Kurth LLP
